Magnetic, Luminescent and Hybrid Nanoplatforms as Anti-Cancer Drug Delivery Systems: From Targeted Therapy to Translational Pharmacology

  • 1,238

    Total views and downloads

About this Research Topic

Submission deadlines

  1. Manuscript Submission Deadline 2 February 2027

  2. This Research Topic is currently accepting articles

Background

Theranostic nanomedicine has emerged as a powerful approach for integrating diagnosis, imaging, targeted therapy, and real-time therapeutic monitoring within a single platform. Magnetic nanomaterials are emerging as precision drug delivery systems enabling magnetically guided accumulation, controlled release, and hyperthermia-based combination therapy with conventional anti-cancer drugs. Luminescent nanoplatforms, particularly in the near-infrared (NIR) window, allow real-time monitoring of drug biodistribution and therapeutic response at the tumor site. Together, hybrid opto-magnetic nanosystems offer an integrated pharmacological toolkit for personalized oncology. In parallel, advances in stimuli-responsive systems, multimodal imaging, AI-assisted diagnostics, and combination therapies have accelerated the development of next-generation nanotheranostics.

This Research Topic aims to provide a platform for researchers working on nanomedicine systems for cancer, with emphasis on multifunctional design, therapeutic precision, and translational potential. It will cover innovative nanocarrier engineering, nano-bio interactions, imaging and therapeutic strategies, preclinical evaluation, and emerging perspectives toward clinical translation.

Topics of interest include:
• Magnetically controlled and stimuli-responsive nanomedicine for spatiotemporal drug delivery
• Magnetic hyperthermia and integrated combination therapies
• NIR-luminescent nanocarriers for real-time pharmacokinetic monitoring and drug response assessment in vivo
• Photoactivated nanotherapeutics
• Opto-magnetic and hybrid nanocarriers for spatiotemporally controlled co-delivery of anti-cancer agents
• Targeted nanomedicine for cancer
• Nano–bio interactions, pharmacokinetics, and biosafety
• Preclinical validation and translational perspectives towards clinical application

Research Topic Research topic image

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Case Report
  • Clinical Trial
  • Data Report
  • Editorial
  • FAIR² Data
  • General Commentary
  • Hypothesis and Theory
  • Methods

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: Theranostic nanomedicine, Magnetic nanoparticles, Drug delivery systems, Near-infrared (NIR) luminiscence, Targeted cancer therapy, Magnetic hyperthermia, Photoactivated nanotherapeutics, Magnetic/luminescent hybrid nanomedicine

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 1,238Topic views
View impact